Antituberculosis drug resistance rates in patients newly diagnosed with TB in Istanbul

O. Sezer, F. Ciftci, E. Bozkanat, T. Ozkisa, H. Kaya, T. Ursavas, Z. Kartaloglu (Ankara, Istanbul, Turkey)

Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Session: Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Session type: Thematic Poster Session
Number: 2681
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Sezer, F. Ciftci, E. Bozkanat, T. Ozkisa, H. Kaya, T. Ursavas, Z. Kartaloglu (Ankara, Istanbul, Turkey). Antituberculosis drug resistance rates in patients newly diagnosed with TB in Istanbul. Eur Respir J 2012; 40: Suppl. 56, 2681

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antituberculous drug resistance rates in soldier patients newly diagnosed with TB in Turkey
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Drug resistance rates in soldier patients newly diagnosed with TB
Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups
Year: 2008


Spreading of resistance to group A anti-tuberculosis drugs among TB patients in Astana city
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018


Resistance pattern to WHO category IV anti tuberculous drugs in patients suspected of multidrug resistance tuberculosis presenting to a specialist clinic in Maharashtra, India
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006

Drug resistant tuberculosis in hospitalized patients
Source: Eur Respir J 2006; 28: Suppl. 50, 10s
Year: 2006

Tuberculous bacillus drug resistance in hospitalized patients with drug resistant tuberculosis in Massih Daneshvari Hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 524s
Year: 2003

The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012

First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009

Investigating trends in antituberculosis (anti-TB) drug resistance among treated patients of a university respiratory infections unit in Greece
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


The pattern of drug resistance in hospitalized patients with drug resistant tuberculosis in Massih Daneshvari Hospital
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004


Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Drug resistant TB treatment outcomes in Novokuznetsk
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007


Relapse rate in tuberculosis patients folowed-up in two dispensaries in Istanbul
Source: Eur Respir J 2003; 22: Suppl. 45, 39s
Year: 2003

Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002

Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002

Prevalance of initial and acquired resistance to antituberculosis drugs in our clinic
Source: Eur Respir J 2005; 26: Suppl. 49, 653s
Year: 2005

Particularities of a cohort of preXDR / XDR TB patients treated with group 5 medication, hospitalized in MDR TB Department Institute of Pneumophtisiology Bucharest, Romania
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


First-line anti-TB drug resistance pattern and its trend in the national TB referral center in Iran
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008